v3.26.1
Business, Presentation and Recent Accounting Pronouncements (Details)
6 Months Ended 12 Months Ended
Jun. 30, 2026
USD ($)
segment
Dec. 31, 2025
USD ($)
Subsidiary, Sale of Stock [Line Items]    
Cash and cash equivalents $ 7,076,533 $ 8,696,570
Short-term investments 9,761,994 8,392,513
Accumulated deficit 158,714,270 154,217,276
Deferred collaboration revenue $ 1,250,000 1,250,000
Number of operating segments | segment 1  
Number of reportable segments | segment 1  
Number of geographic areas | segment 3  
Income taxes receivable $ 700,000 700,000
In Process R&D    
Subsidiary, Sale of Stock [Line Items]    
In-Process R&D Impairment   4,600,000
Indefinite-lived intangible assets $ 2,100,000 $ 2,100,000